Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Phillip M. Devlin, MD, FACR


Radiation Oncology

Make an Appointment

Physician

  • Chief, Division of Brachytherapy
  • Institute Physician
  • Associate Professor of Radiation Oncology, Harvard Medical School

Clinical Interests

  • Brachytherapy for all sites
  • Brachytherapy training
  • Cutaneous oncology
  • Image-guided brachytherapy

Diseases Treated

Contact Information

  • Appointments617-732-7936
  • Office Phone Number617-732-7936
  • Fax617-394-2669

Bio

Phillip Devlin, MD, FACR is Associate Professor of Radiation Oncology at Harvard Medical School and Chief of the Division of Brachytherapy in the Department of Radiation Oncology at the Dana-Farber/Brigham and Women’s Cancer Center.  He earned his medical degree at the University of Virginia School of Medicine in 1991 and completed his residency in Radiation Oncology at the University of Pennsylvania in 1995, followed by a specialized fellowship in brachytherapy at Memorial Sloan-Kettering Cancer Center in 1996.  Dr. Devlin joined the staff of Dana-Farber in 1997.In addition to lecturing extensively both nationally and internationally, Dr. Devlin established and directs the Harvard Medical School Annual Brachytherapy Review Course, has more than 50 published manuscripts and book chapters and is editor of the Lippincott, Williams and Wilkins’ text, Brachytherapy: Applications and Techniques.  Dr. Devlin is currently on the Executive Committees of both the American Society for Radiation Oncology (ASTRO) and the Massachusetts Radiological Society.  In 2008 he was named a Fellow of the American College of Radiology (FACR), and he is currently leading two funded studies as part of the ACR’s Quality Research in Radiation Oncology (QRRO) project.

Board Certification:

  • Radiation Oncology

Fellowship:

  • Memorial Sloan Kettering Cancer Center, Brachytherapy

Residency:

  • Georgetown University Medical Center, Surgery
  • University of Pennsylvania School of Medicine, Radiation Oncology

Medical School:

  • University of Virginia School of Medicine

Research

Dr. Devlin studies genetic markers for oral cavity cancer.

Mutyala S, Stewart A, Khan AJ, Cormack RA, O'Farrell D, Sugarbaker D, Devlin PM.  Permanent Iodine-125 Interstitial Planar Seed Brachytherapy for Close or Positive Margins for Thoracic Malignancies. Int J Radiat Oncol Biol Phys. 2010 Mar; 76(4):1114-1120.

2010

Stewart AJ, Khan AJ, Devlin PM. Partial breast irradiation: a review of techniques and indications. Br J Radiol. 2010 May;83(989):369-78. Epub 2010 Mar 11.

2010

Ahmed HM, Dipiro PJ, Devlin PM, Nguyen ML, Bellon JR. Mammographic Appearance Following Accelerated Partial Breast Irradiation by Using MammoSite Brachytherapy. Radiology. 2010 May;255(2):362-8. Epub 2010 Mar 23.

2010

Cotter SE, Devlin PM, Sahni D, Hansen JL, O'Farrell DA, Ng AK, Wang LC. Treatment of cutaneous metastases of Merkel cell carcinoma with surface-mold computer-optimized high-dose-rate brachytherapy.  Journal of Clinical Oncology. 2010 Sep 20;28(27):e464-6. Epub 2010 Aug 2.

2010

Sher DJ, Posner MR, Tishler RB, Sarlis NJ, Haddad RI, Holupka EJ, Devlin PM. Relationship Between Radiation Treatment Time and Overall survival After Induction Chemotherapy for Locally Advanced Head-and-Neck Carcinoma: A subset Analysis of TAX 324. Int J Radiat Oncol Biol Phys. 2011 Feb 10. {Epub ahead of print}

2011

Cotter SE, Dunn GP, Collins KM, Sahni D, Zukotynski KA, Hansen JL, O'Farrell DA, Ng AK, Devlin PM, Wang LC. Abscopal effect in a patient with metastatic merkel cell carcinoma following radiation therapy: potential role of induced antitumor immunity. Arch Dermatol. 2011 Jul;147(7):870-2. 

2011

Nguyen PL, Devlin PM, Beard CJ, Orio PF 3rd, O'Leary MP, Wolfsberger LD, O'Farrell DA, Sweeney CM, Hadaschik BA, Hohenfellner M, Hatiboglu G. High-dose-rate brachytherapy for prostate cancer in a previously radiated patient with polyethylene glycol hydrogel spacing to reduce rectal dose: Case report and review of the literature. Brachytherapy. 2012 Apr 28. [Epub ahead of print]

2012

Zelefsky MJ, Cohen GN, Bosch WR, Morikawa L, Khalid N, Crozier CL, Lee WR, Zietman A, Owen J, Wilson JF, Devlin PM. Results from the Quality Research in Radiation Oncology (QRRO) survey: Evaluation of dosimetric outcomes for low-dose-rate prostate brachytherapy. Brachytherapy. 2012 Jul 20. [Epub ahead of print]

2012

Goodman KA, Khalid N, Kachnic LA, Minsky BD, Crozier C, Owen JB, Devlin PM, Thomas CR Jr. Quality Research in Radiation Oncology Analysis of Clinical Performance Measures in the Management of Gastric Cancer. Int J Radiat Oncol Biol Phys. 2012 Oct 2. [Epub ahead of print]

2012

Baldini EH, Lapidus MR, Wang Q, Manola J, Orgill DP, Pomahac B, Marcus KJ, Bertagnolli MM, Devlin PM, George S, Abraham J, Ferrone ML, Ready JE, Raut CP. Predictors for Major Wound Complications Following Preoperative Radiotherapy and Surgery for Soft-Tissue Sarcoma of the Extremities and Trunk: Importance of Tumor Proximity to Skin Surface. Ann Surg Oncol. 2012 Dec 15. [Epub ahead of print]

2012

Research Departments:

Location

Brigham and Women's Hospital
75 Francis Street
ASB1 L2
Boston, MA 02115
Get Directions

Ratings

Top